Decheng Capital LLC
14 holdingsFiling period: 2026-06-30Current AUM: $614.9Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | CGON | CG Oncology Inc | 6.37M | $452.7M | $412.1M | 67.03% | -- | 2026-06-30 |
| 2 | NUVB | Nuvation Bio Inc. | 25.95M | $147.4M | $123.5M | 20.09% | -- | 2026-06-30 |
| 3 | AARD | Aardvark Therapeutics Inc | 3.92M | $22.6M | $5.3M | 0.87% | -- | 2026-06-30 |
| 4 | ACRS | Aclaris Therapeutics, Inc. | 4.04M | $21.4M | $16.0M | 2.61% | -- | 2026-06-30 |
| 5 | UPB | Upstream Bio Inc. | 2.72M | $18.9M | $9.3M | 1.51% | -- | 2026-06-30 |
| 6 | RCUS | Arcus Biosciences, Inc | 464.8K | $14.3M | $8.5M | 1.37% | -13,040 | 2026-06-30 |
| 7 | EQ | Equillium Inc. | 4.45M | $14.2M | $6.1M | 0.99% | -- | 2026-06-30 |
| 8 | RVMD | Revolution Medicines Inc(Nsm) | 52.7K | $9.9M | $10.1M | 1.64% | -40,833 | 2026-06-30 |
| 9 | LYEL | Lyell Immunopharma, Inc. | 692.0K | $9.7M | $7.6M | 1.24% | -- | 2026-06-30 |
| 10 | — | BeyondSpring Inc. | 3.80M | $6.7M | $6.7M | 1.08% | -- | 2026-06-30 |
| 11 | ZNTL | Zentalis Pharmaceuticals Inc. | 1.32M | $6.4M | $2.6M | 0.42% | -- | 2026-06-30 |
| 12 | — | Newamsterdam Pharma Co NV | 176.9K | $6.0M | $6.0M | 0.97% | -148,170 | 2026-06-30 |
| 13 | PYXS | Pyxis Oncology, Inc (formerly Apexigen) | 326.8K | $983K | $591K | 0.10% | -- | 2026-06-30 |
| 14 | TNGX | Tango Therapeutics Inc | 20.0K | $625K | $454K | 0.07% | -- | 2026-06-30 |
← Scroll →